Novartis India

Rediff.com » News » Novartis India

News for Novartis India

Business

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Why price cap on drugs is counter productive

To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters, says Ranjit Shahani. India is the fourth fastest growing economy in......

Winning spree intact; Sensex, Nifty soar 5% in 3 sessions

Markets gained for the fourth straight session with Nifty settling above the 8,150 levels comfortably supported by sustained buying across the board especially the index heavyweights like......

Court bars Cipla from selling copy of Novartis respiratory drug

The Delhi High Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically, citing infringement of patents......

Rediff News

Novartis India

News for Novartis India

Budget 2023: What the pharma, healthcare industry seek

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Why price cap on drugs is counter productive

Winning spree intact; Sensex, Nifty soar 5% in 3 sessions

Court bars Cipla from selling copy of Novartis respiratory drug

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS